Clinical Trial Shows Keto Diet Reduces Liver Fat More Than Other Diets
A recent clinical trial published on August 27 in the journal Cell Metabolism reveals that a very low-carbohydrate, high-fat ketogenic diet may provide greater metabolic benefits for individuals with obesity compared to Mediterranean and low-fat diets. The study involved 42 participants diagnosed with obesity, prediabetes, and fatty liver disease, who were randomly assigned to follow one of the three diets for four to five months. The ketogenic diet, which limited carbohydrate intake to just 4% of total calories and derived 73% of calories from fat, resulted in significant metabolic improvements. By the end of the study, participants on the ketogenic diet saw their liver fat decrease by an average of 67%, while those on the Mediterranean and low-fat diets experienced reductions of 45%. Despite the high fat intake, participants on the ketogenic diet did not show an increase in blood fat or cholesterol levels, a finding that surprised researchers. Insulin sensitivity improved across all groups, but the most notable improvement was observed in the ketogenic group, where about 50% of participants no longer met the criteria for prediabetes, compared to 29% in the Mediterranean group and only 7% in the low-fat group. The study, led by Samuel Klein from Washington University School of Medicine, suggests that reducing carbohydrate intake can have therapeutic effects on metabolism beyond weight loss alone. The research was supported by the National Institutes of Health and the Foundation for Barnes-Jewish Hospital, highlighting the importance of diet composition in managing metabolic health issues.




